share_log

HC Wainwright & Co. Reiterates Buy on Vor Biopharma, Maintains $17.5 Price Target

Benzinga ·  Sep 6 18:28  · Ratings

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Vor Biopharma (NASDAQ:VOR) with a Buy and maintains $17.5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment